CBP-IN-1
Cat. No.:YN310117
| 产品名称: | CBP-IN-1 |
| CAS No.: | 2222941-37-7 |
| Chemical Name: | (6S)-1-(3,4-difluorophenyl)-6-[5-(3,5-dimethyl-4-isoxazolyl)-1-(trans-4-methoxycyclohexyl)-1H-benzimidazol-2-yl]-2-piperidinone |
| Synonyms: | CBP-IN-1, CBP/p300-IN-4 |
| 分子量: | 534.60 |
| 分子式: | C₃₀H₃₂F₂N₄O₃ |
| SMILES: | O=C1N(C2=CC=C(F)C(F)=C2)[C@H](C3=NC4=CC(C5=C(C)ON=C5C)=CC=C4N3[C@H]6CC[C@H](OC)CC6)CCC1 |
| 存储: | Please store the product under the recommended conditions in theCertificate of Analysis. |
| 运输: | Room temperature in continental US; may vary elsewhere. |
| 产品描述: | CBP-IN-1 是一种高效p300/CBP溴结构域抑制剂。 |
| IC50和靶点: | |
| In Vitro: | |
| In Vivo: | |
| Clinical Trial: | |
| Solvent & Solubility: |
Brooks, N., Raja, M., Young, B.W., et al.CCS1477: A novel small molecule inhibitor of p300/CBP bromodomain for the treatment of acute myeloid leukaemia and multiple myelomaBlood134(Supplement 1),2560(2019)